| Inhalable microparticles containing large payload of anti-tuberculosis drugs P Muttil, J Kaur, K Kumar, AB Yadav, R Sharma, A Misra European Journal of Pharmaceutical Sciences 32 (2), 140-150, 2007 | 219 | 2007 |
| Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice RK Verma, J Kaur, K Kumar, AB Yadav, A Misra Antimicrobial agents and chemotherapy 52 (9), 3195-3201, 2008 | 108 | 2008 |
| A hand-held apparatus for “nose-only” exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages J Kaur, P Muttil, RK Verma, K Kumar, AB Yadav, R Sharma, A Misra European journal of pharmaceutical sciences 34 (1), 56-65, 2008 | 90 | 2008 |
| Enzyme‐and transporter‐mediated beverage–drug interactions: An update on fruit juices and green tea G An, JK Mukker, H Derendorf, RF Frye The Journal of Clinical Pharmacology 55 (12), 1313-1331, 2015 | 57 | 2015 |
| Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaques RK Verma, JK Mukker, RSP Singh, K Kumar, PRP Verma, A Misra Molecular pharmaceutics 9 (4), 1011-1016, 2012 | 39 | 2012 |
| Determination of atypical nonlinear plasma–protein-binding behavior of tigecycline using an in vitro microdialysis technique JK Mukker, RP Singh, H Derendorf Journal of Pharmaceutical Sciences 103 (3), 1013-1019, 2014 | 33 | 2014 |
| Permeability and conjugative metabolism of flaxseed lignans by Caco-2 human intestinal cells JK Mukker, D Michel, AD Muir, ES Krol, J Alcorn Journal of natural products 77 (1), 29-34, 2014 | 33 | 2014 |
| Ciclesonide: a pro-soft drug approach for mitigation of side effects of inhaled corticosteroids JK Mukker, RSP Singh, H Derendorf Journal of pharmaceutical sciences 105 (9), 2509-2514, 2016 | 31 | 2016 |
| Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats JK Mukker, RSP Singh, AD Muir, ES Krol, J Alcorn British Journal of Nutrition 113 (5), 749-757, 2015 | 30 | 2015 |
| HPLC method with fluorescence detection for the quantitative determination of flaxseed lignans JK Mukker, V Kotlyarova, RSP Singh, J Alcorn Journal of Chromatography B 878 (30), 3076-3082, 2010 | 29 | 2010 |
| Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy JK Mukker, RSP Singh, H Derendorf Advanced drug delivery reviews 85, 57-64, 2015 | 25 | 2015 |
| Advances in nanoparticle-based delivery of next generation peptide nucleic acids S Malik, B Asmara, Z Moscato, JK Mukker, R Bahal Current Pharmaceutical Design 24 (43), 5164-5174, 2018 | 18 | 2018 |
| A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding RSP Singh, JK Mukker, SK Drescher, AN Deitchman, H Derendorf International journal of antimicrobial agents 49 (4), 449-455, 2017 | 18 | 2017 |
| Role of divalent metal ions in atypical nonlinear plasma protein binding behavior of tigecycline RSP Singh, JK Mukker, AN Deitchman, SK Drescher, H Derendorf Journal of Pharmaceutical Sciences 105 (11), 3409-3414, 2016 | 14 | 2016 |
| Pharmacokinetic and pharmacodynamic studies on flaxseed lignans J Mukker University of Saskatchewan, 2013 | 10 | 2013 |
| Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one month AK Singh, RK Verma, JK Mukker, AB Yadav, P Muttil, R Sharma, M Mohan, ... Tuberculosis 128, 102081, 2021 | 9 | 2021 |
| Pharmacokinetic modeling in nano-formulations: concept, implementation and challenges JK Mukker, RSP Singh Current Pharmaceutical Design 24 (43), 5175-5180, 2018 | 8 | 2018 |
| Pharmacokinetic and pharmacodynamic considerations in elderly population JK Mukker, RSP Singh, H Derendorf Developing drug products in an aging society: from concept to prescribing …, 2016 | 7 | 2016 |
| 457MO A phase I study of ATR inhibitor M1774 in patients with solid tumours (DDRiver Solid Tumours 301): Part A1 results TA Yap, AW Tolcher, R Plummer, J Mukker, M Enderlin, C Hicking, ... Annals of Oncology 33, S747-S748, 2022 | 6 | 2022 |
| The pharmacokinetics of oral trazpiroben (TAK‐906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study JK Mukker, G Dukes, M Tolkoff, L Wang, C Almansa, SY Huh, M Nishihara, ... Clinical and Translational Science 15 (6), 1532-1543, 2022 | 3 | 2022 |
Amit MisraScientist, CSIR-Central Drug Research Institute, Lucknow, IndiaDirección de correo verificada de cdri.res.in
